Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2008
11/06/2008US20080274095 Using antiprotozoal fusion to target and destroy cryptosporidium contaminants in health care, agriculture and food processing environments
11/06/2008US20080274094 Molecular Complex Comprising Arbutine, Ascorbic Acid, Oleuropeina or Its Derivatives Thereof and Related Uses In Medical Field
11/06/2008US20080274082 Oximyl hydroxyamic analogs as hepatitis c virus protease inhibitor
11/06/2008US20080274081 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
11/06/2008US20080274080 Aza-peptide macrocyclic hepatitis c serine protease inhibitors
11/06/2008US20080274079 Using mifepristone, cacl2, and/or metyrapone as therapeutic antagonist in treatment of skin disorders; wound healing agents; antiscarring agents
11/06/2008US20080274078 Novel uses
11/06/2008US20080274077 Using Nogo receptor suppressant as therapeutic in treatment of nervous system and neurodegenerative disorders; axonal regeneration
11/06/2008US20080274056 Nanoparticle delivery systems for membrane-integrating peptides
11/06/2008US20080274045 Imaging, diagnosis and treatment of disease
11/06/2008US20080273660 Compositions and Methods for Modulating DNA Repair
11/06/2008DE102007020254A1 Use of an agent reducing the bioavailability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to prepare a medicament, especially for treating allergic diseases
11/06/2008CA2722465A1 Compositions for prevention of adhesions and other barrier applications
11/06/2008CA2685756A1 Citrullinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis
11/06/2008CA2685737A1 Methods and compositions for the treatment of cancer
11/06/2008CA2685593A1 Combination pharmaceutical compositions
11/06/2008CA2685522A1 High viscosity macromolecular compositions for treating ocular conditions
11/06/2008CA2685428A1 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
11/06/2008CA2685405A1 Modified phosphatases
11/06/2008CA2685400A1 Production of high mannose proteins in plant culture
11/06/2008CA2685124A1 Products for altering il-33 activity and methods therefor
11/06/2008CA2685115A1 Igf-1r binding proteins and antagonists
11/06/2008CA2684529A1 Treatment of movement disorders by a combined use of botulinum toxin and muscle stimulation
11/06/2008CA2683317A1 Stabilization of liquid solutions of recombinant protein for frozen storage
11/06/2008CA2683071A1 A method for detecting the binding between mdm2 and the proteasome
11/06/2008CA2679658A1 Fusion proteins binding to growth factors
11/06/2008CA2676808A1 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf)
11/06/2008CA2669315A1 Ablative immunotherapy
11/06/2008CA2669049A1 Binary epitope antibodies and b cell superantigen immune stimulants
11/06/2008CA2667195A1 Antimicrobial and antiviral compounds and methods for their use
11/05/2008EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity
11/05/2008EP1988163A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
11/05/2008EP1988102A1 Growth factor homolog ZVEGF3
11/05/2008EP1988100A1 Derivatives of glucagon-like peptide-2 and their therapeutic use
11/05/2008EP1988098A1 Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors
11/05/2008EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/05/2008EP1987845A2 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor.
11/05/2008EP1987842A1 Cell proliferation inhibitor
11/05/2008EP1987838A1 Novel compound for treatment of tumor
11/05/2008EP1987837A1 Pharmaceutical composition for increasing insulin secretion from pancreatic ß-cells
11/05/2008EP1987836A1 Protective staphylococcus aureus vaccine based on cell wall-associated proteins
11/05/2008EP1987817A2 Pharmaceutical composition of microspheres for preventing diabetic foot amputation
11/05/2008EP1987804A1 Implantable system for an intervertebral disc and intervertebral disc implant
11/05/2008EP1987726A1 Good tasting food product containing a neutralisation agent for adverse compounds
11/05/2008EP1987359A2 Vascular tumor markers
11/05/2008EP1987144A1 DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh
11/05/2008EP1987063A1 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/05/2008EP1987062A1 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
11/05/2008EP1987061A1 Soluble receptors and methods for treating autoimmune or demyelinating diseases
11/05/2008EP1987060A2 Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same
11/05/2008EP1987059A2 Adir related polymorphisms and applications thereof
11/05/2008EP1987057A2 Peptide aptamer for neutralizing the binding of platelet antigene specific antibodies and diagnostic and therapeutic applications containing the same
11/05/2008EP1987055A1 Novel antimicrobial peptides and use thereof
11/05/2008EP1987054A1 Purification and use of a factor for supporting wound healing
11/05/2008EP1986683A2 Compositions and methods for effecting controlled posterior vitreous detachment
11/05/2008EP1986682A2 Methods and compositions related to targeting tumors and wounds
11/05/2008EP1986681A2 Compositions and methods for modulating hemostasis using variant forms of activated factor v
11/05/2008EP1986680A2 Intraventricular protein delivery for amyotrophic lateral sclerosis
11/05/2008EP1986679A2 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
11/05/2008EP1986678A1 Dissolution aids for oral peptide delivery comprising a biguanide
11/05/2008EP1986677A2 Thrombopoietic compounds
11/05/2008EP1986676A2 Compositions and methods for use of pigment epithelial derived factor (pedf) peptide fragments
11/05/2008EP1986675A2 Extracellular matrix/metastasis modifer genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor
11/05/2008EP1986674A2 Methionine-containing protein or peptide compositions and methods of making and using
11/05/2008EP1986673A2 Methods and compositions related to ghs-r antagonists
11/05/2008EP1986668A2 Mapc therapeutics without adjunctive immunosuppressive treatment
11/05/2008EP1986657A2 Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor
11/05/2008EP1986655A2 Osteoporosis associated markers and methods of use thereof
11/05/2008EP1986634A2 Synergistic pharmaceutical composition containing a peptide with 2 to 5 amino acids
11/05/2008EP1986629A2 Platelet stabilization
11/05/2008EP1986612A2 Stabilized compositions of proteins having a free thiol moiety
11/05/2008EP1740201B1 Pharmaceutical compositions comprising interferon-tau
11/05/2008EP1696944A4 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
11/05/2008EP1664275A4 In vivo synthesis of connective tissues
11/05/2008EP1549246A4 Antibiotic microspheres for treatment of infections and osteomyelitis
11/05/2008EP1505945B1 Substituted cycloalkyl p1' hepatitis c virus inhibitors
11/05/2008EP1465996B1 Raf/ras binding compounds
11/05/2008EP1393739B1 Adiponection for liver regeneration
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP1341811B9 Orally ingestible preparation of mistletoe lectins and method
11/05/2008EP1223941B1 Therapeutic treatments for blood cell deficiencies using sreroids
11/05/2008EP1196193B1 Interleukin-1 mutein useful as vaccine adjuvant
11/05/2008EP1162990B1 Treatment with small peptides to effect antifibrotic activity
11/05/2008EP1140172B1 The prevention and treatment for retinal ischemia and edema
11/05/2008EP1104323B1 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
11/05/2008EP1003532B2 Lactobacilli to increase absorption of minerals by intestinal cells
11/05/2008EP0994724B1 Methods and compositions for impairing multiplication of hiv-1
11/05/2008EP0927196B1 Polymers containing polysaccharides such as alginates or modified alginates
11/05/2008EP0912601B2 Suppression of immune response via inhibition of cathepsin s
11/05/2008CN101300361A Aptamers to von willebrand factor and their use as thrombotic disease therapeutics
11/05/2008CN101300346A Novel biological substance nesfatin and its related substances and uses thereof
11/05/2008CN101300274A Immunomodulatory compositions and uses therefor
11/05/2008CN101300269A Mecano growth factor peptides and their use
11/05/2008CN101300025A Use of calcitonin for the treatment of RA
11/05/2008CN101300024A Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
11/05/2008CN101300023A Use of vaccines for the treatment/ prevention of the transmission of influenza pathogens between species
11/05/2008CN101300022A Antifungal peptides and methods of use thereof
11/05/2008CN101300021A Antibodies and uses thereof
11/05/2008CN101300014A Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
11/05/2008CN101298627A Improved assays for s-adenosylmethionine (SAM)
1 ... 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 ... 3163